OTC Markets OTCPK - Delayed Quote USD
Propanc Biopharma, Inc. (PPCB)
6.46
+0.96
+(17.45%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 9 | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| NATHANIELSZ JAMES ANDREW Chief Executive Officer | -- | Indirect | -- | Aug 17, 2021 |
| KENYON JULIAN NORMAN Officer and Director | -- | Direct | -- | Aug 17, 2021 |
| NATHANIELSZ JAMES ANDREW Chief Executive Officer | Sale at price 0.09 - 0.20 per share. | Indirect | 60,083 | Jul 5, 2013 |
Related Tickers
ENDV Endonovo Therapeutics, Inc.
0.0002
0.00%
KTTA Pasithea Therapeutics Corp.
1.6300
+5.84%
KZIA Kazia Therapeutics Limited
3.3250
-3.76%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.4200
+9.23%
GBLX GB Sciences, Inc.
0.0002
0.00%
CDT Conduit Pharmaceuticals Inc.
0.5565
-4.22%
VRTX.MX Vertex Pharmaceuticals Incorporated
9,360.00
0.00%
ARTH Arch Therapeutics, Inc.
0.1608
0.00%
MTEM Molecular Templates, Inc.
0.0001
0.00%
RADX Radiopharm Theranostics Limited
4.0500
-3.34%